Canada markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
28.51-0.62 (-2.13%)
At close: 01:00PM EST
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
246,788
161,855
103,303
50,294
Selling General and Administrative
78,303
58,243
45,813
33,169
Total Operating Expenses
325,091
220,098
149,116
83,463
Operating Income or Loss
-325,091
-220,098
-149,116
-83,463
Total Other Income/Expenses Net
3,546
-5,393
-3,274
-46,433
Income Before Tax
-317,758
-225,334
-152,166
-128,344
Income Tax Expense
0
0
-24
45
Income from Continuing Operations
-317,758
-225,334
-152,142
-128,389
Net Income
-317,758
-225,334
-152,142
-128,389
Net Income available to common shareholders
-317,758
-225,334
-152,142
-128,389
Basic EPS
-
-1.65
-2.01
-1.01
Diluted EPS
-
-1.65
-2.01
-1.01
Basic Average Shares
-
136,577
73,643
127,124
Diluted Average Shares
-
136,577
73,643
127,124
EBITDA
-
-217,367
-148,719
-83,286